Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension.

Taguchi I, Toyoda S, Takano K, Arikawa T, Kikuchi M, Ogawa M, Abe S, Node K, Inoue T.

Hypertens Res. 2013 Jul;36(7):608-13. doi: 10.1038/hr.2013.3. Epub 2013 Feb 21.

PMID:
23425956
[PubMed - indexed for MEDLINE]
3.

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.

Derosa G, Cicero AF, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Fassi R, Fogari R.

Clin Ther. 2007 Apr;29(4):602-10.

PMID:
17617283
[PubMed - indexed for MEDLINE]
4.

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.

Rizos CV, Milionis HJ, Kostapanos MS, Florentin M, Kostara CE, Elisaf MS, Liberopoulos EN.

Clin Ther. 2010 Mar;32(3):492-505. doi: 10.1016/j.clinthera.2010.03.018.

PMID:
20399986
[PubMed - indexed for MEDLINE]
5.
6.

Effects of irbesartan on inflammatory cytokine concentrations in patients with chronic glomerulonephritis.

Tsuruoka S, Kai H, Usui J, Morito N, Saito C, Yoh K, Yamagata K.

Intern Med. 2013;52(3):303-8. Epub 2013 Feb 1.

PMID:
23370736
[PubMed - indexed for MEDLINE]
Free Article
8.

Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor γ.

Takai S, Jin D, Miyazaki M.

J Pharmacol Sci. 2011;116(3):309-15. Epub 2011 Jun 18.

PMID:
21691037
[PubMed - indexed for MEDLINE]
Free Article
9.

Effects of antihypertensive treatment with angiotensin II receptor blockers on lipid profile: an open multi-drug comparison trial.

Kyvelou SM, Vyssoulis GP, Karpanou EA, Adamopoulos DN, Zervoudaki AI, Pietri PG, Stefanadis CI.

Hellenic J Cardiol. 2006 Jan-Feb;47(1):21-8.

PMID:
16532712
[PubMed - indexed for MEDLINE]
Free Article
10.

Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.

O'Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, Stanton A.

Hypertension. 2007 Feb;49(2):276-84. Epub 2006 Dec 11.

PMID:
17159081
[PubMed - indexed for MEDLINE]
Free Article
11.

AT1-receptor antagonism in hypertension: what has been learned with irbesartan?

Waeber B, Burnier M.

Expert Rev Cardiovasc Ther. 2003 May;1(1):23-33. Review.

PMID:
15030294
[PubMed - indexed for MEDLINE]
12.

Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.

Derosa G, Cicero AF, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Ferrari I, Gravina A, Fogari R.

Hypertens Res. 2006 Nov;29(11):849-56.

PMID:
17345784
[PubMed - indexed for MEDLINE]
13.

Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension.

Lethen H, Tries HP, Kersting S, Bramlage P, Lambertz H.

J Clin Hypertens (Greenwich). 2011 Mar;13(3):155-61. doi: 10.1111/j.1751-7176.2010.00401.x. Epub 2010 Dec 13.

PMID:
21366846
[PubMed - indexed for MEDLINE]
15.

[Pharmacological properties and clinical efficacy of the long-active angiotensin receptor blocker (ARB) irbesartan].

Ariyoshi Y, Mizumoto K.

Nihon Yakurigaku Zasshi. 2009 May;133(5):275-80. Review. Japanese. No abstract available.

PMID:
19443965
[PubMed - indexed for MEDLINE]
16.

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study.

Parhofer KG, Münzel F, Krekler M.

Cardiovasc Diabetol. 2007 Nov 27;6:36.

PMID:
18042288
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.

Sakamoto M, Suzuki H, Hayashi T, Iuchi H, Isaka T, Sakamoto N, Kayama Y, Tojo K, Yoshimura M, Utsunomiya K.

Cardiovasc Diabetol. 2012 Oct 3;11:118. doi: 10.1186/1475-2840-11-118.

PMID:
23034088
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Comparison of the effects of quinapril and irbesartan on P-wave dispersion in hypertensive patients.

Guntekin U, Gunes Y, Tuncer M, Simsek H, Gunes A.

Adv Ther. 2008 Aug;25(8):775-86. doi: 10.1007/s12325-008-0083-1.

PMID:
18670740
[PubMed - indexed for MEDLINE]
19.

Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.

Derosa G, Fogari E, D'Angelo A, Cicero AF, Salvadeo SA, Ragonesi PD, Ferrari I, Gravina A, Fassi R, Fogari R.

J Clin Pharm Ther. 2007 Jun;32(3):261-8.

PMID:
17489878
[PubMed - indexed for MEDLINE]
20.

BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.

Schrader J, Bramlage P, Lüders S, Thoenes M, Schirmer A, Paar DW.

Clin Drug Investig. 2007;27(11):783-96.

PMID:
17914897
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk